Seth P - Search Results

1

p53 gene transfer to the injured rat carotid artery decreases neointimal formation.

Scheinman M, Ascher E, Levi GS, Hingorani A, Shirazian D, Seth P. Scheinman M, et al. Among authors: seth p. J Vasc Surg. 1999 Feb;29(2):360-9. doi: 10.1016/s0741-5214(99)70389-7. J Vasc Surg. 1999. PMID: 9950994 Free article.

2

P53 gene transfer to the injured rat carotid artery promotes apoptosis.

Scheinman M, Ascher E, Kallakuri S, Hingorani A, Gade P, Sherman M, Seth P, Jacob T. Scheinman M, et al. Among authors: seth p. Surgery. 1999 Nov;126(5):863-8. Surgery. 1999. PMID: 10568186

3

Effect of p53 gene therapy combined with CTLA4Ig selective immunosuppression on prolonged neointima formation reduction in a rat model.

Ascher E, Scheinman M, Hingorani A, Seth P, Marella VK, Jacob T. Ascher E, et al. Among authors: seth p. Ann Vasc Surg. 2000 Jul;14(4):385-92. doi: 10.1007/s100169910077. Ann Vasc Surg. 2000. PMID: 10943792

4

Von Hippel-Lindau gene therapy: a novel strategy in limiting endothelial cell proliferative activity.

Jacob T, Ascher E, Hingorani A, Gunduz Y, Yorkovich W, Seth P. Jacob T, et al. Among authors: seth p. Ann Vasc Surg. 2001 Jan;15(1):1-6. doi: 10.1007/s100160010011. Ann Vasc Surg. 2001. PMID: 11221934

5

The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer.

Rizk NP, Chang MY, El Kouri C, Seth P, Kaiser LR, Albelda SM, Amin KM. Rizk NP, et al. Among authors: seth p. Cancer Gene Ther. 1999 Jul-Aug;6(4):291-301. doi: 10.1038/sj.cgt.7700059. Cancer Gene Ther. 1999. PMID: 10419047

6

Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation.

Srivastava S, Katayose D, Tong YA, Craig CR, McLeod DG, Moul JW, Cowan KH, Seth P. Srivastava S, et al. Among authors: seth p. Urology. 1995 Dec;46(6):843-8. doi: 10.1016/S0090-4295(99)80355-0. Urology. 1995. PMID: 7502427

7

p53 regulates the expression of the tumor suppressor gene maspin.

Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S. Zou Z, et al. Among authors: seth p. J Biol Chem. 2000 Mar 3;275(9):6051-4. doi: 10.1074/jbc.275.9.6051. J Biol Chem. 2000. PMID: 10692390 Free article.

8

Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector.

Asgari K, Sesterhenn IA, McLeod DG, Cowan K, Moul JW, Seth P, Srivastava S. Asgari K, et al. Among authors: seth p. Int J Cancer. 1997 May 2;71(3):377-82. doi: 10.1002/(sici)1097-0215(19970502)71:3<377::aid-ijc13>3.0.co;2-d. Int J Cancer. 1997. PMID: 9139872

9

Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53.

Qazilbash MH, Xiao X, Seth P, Cowan KH, Walsh CE. Qazilbash MH, et al. Among authors: seth p. Gene Ther. 1997 Jul;4(7):675-82. doi: 10.1038/sj.gt.3300444. Gene Ther. 1997. PMID: 9282168

10

p53-dependent induction of heat shock protein 27 (HSP27) expression.

Gao C, Zou Z, Xu L, Moul J, Seth P, Srivastava S. Gao C, et al. Among authors: seth p. Int J Cancer. 2000 Oct 15;88(2):191-4. Int J Cancer. 2000. PMID: 11004667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,006 results

Search Page

Filters